Miroculus Status
The company raised $17.21 million of Series B venture funding from undisclosed investors on August 21, 2018, putting the company's pre-money valuation at $35 million.
Provider of hands-off sample-to-answer solutions designed for molecular testing. The company's solution leverages a proprietary digital microfluidics technology to automate manually intensive experimental workflows on a low-cost cartridge, enabling users to have access to accurate, affordable and minimally invasive molecular testing
Generating Revenue
Privately Held (backing)
Venture Capital-Backed
We are extremely excited to be a part of INTEGRA Biosciences. Accelerating Science Together! https://t.co/8VehnUnOGz
Miroculus is very excited to be an initial member of the PacBio Compatible program! Contact us to learn more about how we can automate library prep for PacBio sequencing systems: https://t.co/5GJeBbazIg https://t.co/DZ3fb5acOh
We had a great time at #ASHG22, thanks to everyone, it was amazing!! Up next #AMPath22
The company raised $17.21 million of Series B venture funding from undisclosed investors on August 21, 2018, putting the company's pre-money valuation at $35 million.
We are extremely excited to be a part of INTEGRA Biosciences. Accelerating Science Together! https://t.co/8VehnUnOGz
Miroculus is very excited to be an initial member of the PacBio Compatible program! Contact us to learn more about how we can automate library prep for PacBio sequencing systems: https://t.co/5GJeBbazIg https://t.co/DZ3fb5acOh
We had a great time at #ASHG22, thanks to everyone, it was amazing!! Up next #AMPath22
Who is ready for #ASHG22 ? We are!! See you all there tomorrow
Phoenix see you soon!!! We can’t wait for #AMPath22 to start! See you there on November 2nd.
Most visits will take between 1.5 and 2 hours. The agenda for a specific visit depends on your group, its interests and objectives as well as on the host company. A visit may include a company or industry specific presentation, a discussion around a specific product or service, partnership opportunities, a demo, a meeting of the premises, etc.
Add a review